| Literature DB >> 23291705 |
William E Carpenter1, Derek Lam, Glenn M Toney, Neal L Weintraub, Zhenyu Qin.
Abstract
Copper and zinc are essential trace biometals that regulate cardiovascular homeostasis, and dysregulation of these metals has been linked to vascular diseases, including hypertension. In this article, we review recent human population studies concerning this topic, focusing on: 1) the relationship between blood pressure and levels of zinc and copper; 2) correlations between trace metals, the renin-angiotensin system, obesity, and hypertension; 3) the relationship between environmental metal pollution and the development of hypertension; and 4) methods commonly employed to assay zinc and copper in human specimens. Moreover, based on the findings of these studies, we suggest the following topics as the basis for future investigations: 1) the potential role of environmental metal pollution as a causal factor for hypertension; 2) metal profiles within specific pathogenic subsets of patients with hypertension; 3) standardizing the experimental design so that the results between different studies are more comparable; and 4) the requirement for animal experiments as complementary approaches to address mechanistic insight that cannot be studied in human populations.Entities:
Year: 2013 PMID: 23291705 PMCID: PMC3628354 DOI: 10.12659/msm.883708
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
A comparison in experimental design between recent human population studies related to copper, zinc and hypertension.
| Year | Subject number | Inclusion criteria | Exclusion criteria | Detailed procedure to diagnosis hypertension | References |
|---|---|---|---|---|---|
| 2009 | Total 2233 (1106 males and 1127 female); hypertensives 731 (348 males and 383 females) | Age 15–65; urban and rural residents; 312 and 88 subjects on treatment with anti-hypertension and anti-diabetic medication, respectively; an overnight fast before biochemical measures | No past medical history of any major disease, no evidence of infectious disease | N/A | M. Ghayour-Mobarhan, et al. |
| 2010 | Hypertensives 78 (56 males, 22 females) | Age 27–59, never treated and newly diagnosed, 13% smoker | No hypercholesterolemia, diabetes mellitus, impaired renal function, coronary or cerebrovascular disease; exclude heavy drunker, chronic inflammatory disease, persistent atrial fibrillation or flutter, women with oral contraceptives or estrogen replacement therapy | When seated arterial blood pressure (after 10min of rest) measured by sphygmomanometer thrice at 1-week intervals was consistently >140/90 mm Hg. Secondary forms of hypertension were excluded by routine diagnostic procedures | de la Sierra A, et al. |
| 2011 | Normotensives 40 (18 males, 22 females); obese hypertensives 40 (13 males, 27 females) | Age 25–65; normal renal and liver function; an overnight fast before biochemical measures | No history of coronary artery disease, stroke, congestive heart failure or malignacy. Secondary obesity, diabetes, other chronic disease, current use of dietary supplements; clinically evident inflammatory process | Resting seated blood pressure was measured three times and an average value was calculated according to The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines | Suliburska, et al. |
| 2009 | Normotensives 114; hypertensives 90 | Age normotensives 35–70, hypertensives 40–85. Part of subjects on treatment with anti-hypertension and anti-diabetic medication | The complete tooth without discoloration and deformity. No history of caries or any type of tooth filing | Blood pressure above 140/80 mmHg | Nagaraj, et al. |
| 2007 | Hypertensives 250 (all males); normotensives 250 (all males) | Mean age 49 | Secondary hypertension | The blood pressures were measured regularly for 2 weeks before the samples of blood and urine were taken. The criteria for hypertension defined by the World Health Organization are systolic and diastolic blood pressures (SP and DP) greater than 140 and/or 90 mmHg, respectively. It was recorded in the seated position by the usual mercury sphygmomanometer | Taneja, et al. |
| 2004 | Hypertensives 109 (male 83, female 26), normotensive 115 (male 85, female 30); match age-gender-socio-economic status | Age 30–58, lacto-vegetarian, rural and urban communities. Around 70% of the subjects had a sedentary level of physical activity | Smokers and alcohol consumtion | diastolic blood pressure of 90 mmHg or higher or systolic blood pressure of 140 mmHg or higher | Chiplonkar, et al. |
Common metal metabolic parameters used for human studies.
| Parameter | Methodology | Values | References |
|---|---|---|---|
| Zinc efflux from lymphocytes | Separate the lymphocytes from the peripheral blood and incubate with zinc chloride (ZnCl2). Then, the cells are incubated in ZnCl2-free medium to determine the efflux rate coefficient of zinc | Varies | S. Tubek, 2006 |
| Zinc concentration in lymphocytes. | AAS | Hypertensive patients: | S. Tubek, 2006 |
| Zinc and copper concentration in plasma | AAS (flame emission) | Normotensive subjects: | Canatan, et al., 2003 |
| Zinc and copper concentration in serum | Digest serum in 3: 1 nitric acid and perchloric acid. Dissolve the formed ash in 10 mM nitric and perchloric acid, filter and analyze the zinc and copper levels by AAS using hollow cathode lamps | Normotensive subjects: | S. Taneja and R. Mandal, 2007 |
| Zinc and copper concentration in urine | Same as described for zinc and copper measurement in serum | Normotensive subjects: | S. Taneja and R. Mandal, 2007 |
| Zinc concentration in erythrocyte membranes | Use concentrated nitric acid to ash the erythrocyte membranes, and then dissolve the ash in nitric acid (30 ml/l). Determine the zinc concentration using AAS (flame emission) | Normotensive subjects: | M Ruz, et al., 1992 |
| Daily dietary metal intake | Conduct a food frequency questionnaire documenting specific quantities of food items consumed throughout the year. A software program is then used to estimate trace metal intake | Normotensive subjects: | S. Chiplonkar, 2004 |
AAS – Atomic Absorption Spectrometry.